Correction to: Pexidartinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 447, doi. 10.1007/s40265-020-01280-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 4
Results: 11
1
2
Lemborexant: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 425, doi. 10.1007/s40265-020-01276-1
- By:
- Publication type:
- Article
3
Avapritinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 433, doi. 10.1007/s40265-020-01275-2
- By:
- Publication type:
- Article
4
Correction to: Sodium Oligomannate: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 445, doi. 10.1007/s40265-020-01274-3
- By:
- Publication type:
- Article
5
Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 401, doi. 10.1007/s40265-020-01272-5
- By:
- Publication type:
- Article
6
Lumateperone: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 417, doi. 10.1007/s40265-020-01271-6
- By:
- Publication type:
- Article
7
Sodium Oligomannate: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 441, doi. 10.1007/s40265-020-01268-1
- By:
- Publication type:
- Article
8
Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 385, doi. 10.1007/s40265-020-01266-3
- By:
- Publication type:
- Article
9
The Rise and Fall "ing" of the HDL Hypothesis.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 353, doi. 10.1007/s40265-020-01265-4
- By:
- Publication type:
- Article
10
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 341, doi. 10.1007/s40265-020-01261-8
- By:
- Publication type:
- Article
11
Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs.
- Published in:
- Drugs, 2020, v. 80, n. 4, p. 363, doi. 10.1007/s40265-020-01259-2
- By:
- Publication type:
- Article